Strategies to mitigate dissociative and psychotomimetic effects of ketamine in the treatment of major depressive episodes: a narrative review

被引:31
作者
Cooper, Matthew D. [1 ,2 ]
Rosenblat, Joshua D. [2 ,3 ]
Cha, Danielle S. [2 ,4 ]
Lee, Yena [2 ]
Kakar, Ron [2 ,5 ,6 ]
McIntyre, Roger S. [2 ,3 ,7 ]
机构
[1] Dalhousie Univ, Med Sci, Halifax, NS, Canada
[2] Univ Hlth Network, Mood Disorders Psychopharmacol Unit, 399 Bathurst St, Toronto, ON, Canada
[3] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[4] Univ Toronto, Inst Med Sci, Toronto, ON, Canada
[5] Western Univ, Dept Psychiat, London, ON, Canada
[6] Western Univ, Dept Psychiat, Windsor, ON, Canada
[7] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada
关键词
Ketamine; depression; adverse effects; intranasal; psychosis; TREATMENT-RESISTANT DEPRESSION; D-ASPARTATE ANTAGONIST; RANDOMIZED-CONTROLLED-TRIAL; FUNCTIONAL PARTIAL AGONIST; NMDA RECEPTOR ANTAGONISTS; PLACEBO-CONTROLLED TRIAL; BIPOLAR II DEPRESSION; LOW-DOSE KETAMINE; OF-CONCEPT TRIAL; INTRAMUSCULAR KETAMINE;
D O I
10.3109/15622975.2016.1139747
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objectives Replicated evidence has demonstrated that ketamine exerts rapid-acting and potent antidepressant effects. Notwithstanding, its promise to mitigate depressive symptoms and suicidality in antidepressant-resistant populations, several limitations and safety concerns accompany ketamine including, but not limited to, the potential for abuse and psychotomimetic/dissociative experiences. The focus of the current narrative review is to synthesise available evidence of strategies that may mitigate and fully prevent treatment-emergent psychotomimetic and dissociative effects associated with ketamine administration. Methods PubMed, Google Scholar and ClinicalTrials.gov were searched for relevant articles. Results Potential avenues investigated to minimise psychotomimetic effects associated with ketamine administration include the following: (1) altering dosing and infusion rates; (2) route of administration; (3) enantiomer choice; (4) co-administration with mood stabilisers of antipsychotics; and (5) use of alternative N-methyl-d-aspartate (NMDA)-modulating agents. Emerging evidence indicates that dissociative experiences can be significantly mitigated by using an intranasal route of administration, lower dosages, or use of alternative NMDA-modulating agents, namely lanicemine (AZD6765) and GLYX-13. Conclusions Currently, intranasal administration presents as the most promising strategy to mitigate dissociative and psychotomimetic effects; however, studies of strategies to mitigate the adverse events of ketamine are limited in number and quality and thus further investigation is still needed.
引用
收藏
页码:410 / 423
页数:14
相关论文
共 62 条
[21]   The epidemiology of major depressive disorder - Results from the National Comorbidity Survey Replication (NCS-R). [J].
Kessler, RC ;
Berglund, P ;
Demler, O ;
Jin, R ;
Koretz, D ;
Merikangas, KR ;
Rush, AJ ;
Walters, EE ;
Wang, PS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (23) :3095-3105
[22]   Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers [J].
Kessler, Ronald C. ;
Akiskal, Hagop S. ;
Ames, Minnie ;
Birnbaum, Howard ;
Greenberg, Paul ;
Hirschfeld, Robert M. A. ;
Jin, Robert ;
Merikangas, Kathleen R. ;
Simon, Gregory E. ;
Wang, Philip S. .
AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (09) :1561-1568
[23]   Pilot dose-response trial of i.v. ketamine in treatment-resistant depression [J].
Lai, Rosalyn ;
Katalinic, Natalie ;
Glue, Paul ;
Somogyi, Andrew A. ;
Mitchell, Philip B. ;
Leyden, John ;
Harper, Simon ;
Loo, Colleen K. .
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2014, 15 (07) :579-584
[24]   A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder [J].
Lapidus, Kyle A. B. ;
Levitch, Cara F. ;
Perez, Andrew M. ;
Brallier, Jess W. ;
Parides, Michael K. ;
Soleimani, Laili ;
Feder, Adriana ;
Iosifescu, Dan V. ;
Charney, Dennis S. ;
Murrough, James W. .
BIOLOGICAL PSYCHIATRY, 2014, 76 (12) :970-976
[25]   Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression [J].
Lara, Diogo R. ;
Bisol, Luisa W. ;
Munari, Luciano R. .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (09) :2111-2117
[26]   RETRACTED: A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department (Retracted article. See vol. 20, pg. 611, 2017) [J].
Larkin, Gregory Luke ;
Beautrais, Annette L. .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2011, 14 (08) :1127-1131
[27]   Ketamine as a novel treatment for major depressive disorder and bipolar depression: a systematic review and quantitative meta-analysis [J].
Lee, Ellen E. ;
Della Selva, Megan P. ;
Liu, Anson ;
Himelhoch, Seth .
GENERAL HOSPITAL PSYCHIATRY, 2015, 37 (02) :178-184
[28]   The Effects of Add-On Low-Dose Memantine on Cytokine Levels in Bipolar II Depression A 12-Week Double- Blind, Randomized Controlled Trial [J].
Lee, Sheng-Yu ;
Chen, Shiou-Lan ;
Chang, Yun-Hsuan ;
Chen, Po See ;
Huang, San-Yuan ;
Tzeng, Nian-Sheng ;
Wang, Yu-Shan ;
Wang, Liang-Jen ;
Lee, I. Hui ;
Wang, Tzu-Yun ;
Yeh, Tzung Lieh ;
Yang, Yen Kuang ;
Hong, Jau-Shyong ;
Lu, Ru-Band .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (03) :337-343
[29]   Neuropsychological and mood effects of ketamine in electroconvulsive therapy: A randomised controlled trial [J].
Loo, Colleen K. ;
Katalinic, Natalie ;
Garfield, Joshua B. B. ;
Sainsbury, Kirby ;
Hadzi-Pavlovic, Dusan ;
Mac-Pherson, Ross .
JOURNAL OF AFFECTIVE DISORDERS, 2012, 142 (1-3) :233-240
[30]   Do the dissociative side effects of ketamine mediate its antidepressant effects? [J].
Luckenbaugh, David A. ;
Niciu, Mark J. ;
Ionescu, Dawn F. ;
Nolan, Neal M. ;
Richards, Erica M. ;
Brutsche, Nancy E. ;
Guevara, Sara ;
Zarate, Carlos A. .
JOURNAL OF AFFECTIVE DISORDERS, 2014, 159 :56-61